Paradigm Biopharmaceuticals Limited (ASX:PAR): Is Breakeven Near?
We feel now is a pretty good time to analyse Paradigm Biopharmaceuticals Limited’s ( ASX:PAR ) business as it…
Rogers: Edward Rogers seeks to assert control – CTV News
Rogers Communications Inc. has declared invalid an attempt by Edward Rogers to replace five members of the company’s board…
Here’s what you missed in Week 7 of Elizabeth Holmes’ Theranos trial – Business Insider
Emails showed Theranos’ former senior product manager was told to change reference ranges to make test results seem normal…
Cian IPO: The Leading Russian Online Real Estate Platform Goes Public On NYSE
Cian PLC filed an F-1 statement, intending to list ADSs on NYSE under the ticker symbol CIAN. The company’s…
S&P 500 Weekly Update II: Street More Cautious On 2022, But Give It Time
It’s clear analysts are very reluctant to get too bullish about 2022.
Why Shares of DoubleVerify Surged 14% Higher This Week
This ad technology stock bucked the industry trend.
recent post
-
Jan 02 2026 -
Jan 02 2026
-
-
Jan 02 2026
-
Jan 02 2026
